News & Topics
Details of the efficacy evaluation of HM-001 will be presented in a poster presentation at the AACR Special Conference in Cancer Research: Bladder Cancer in May 2024.
2024.03.25
We will present a progress report of HM-001 in the MA-T system at the AACR Special Conference: Bladder Cancer:
Transforming the Field, to be held in North Carolina, USA, from May 17, 2024. This presentation will be a more indepth scientific discussion compared to the AACR.
We will report and discuss the evidence that HM-001 is effective for current unmet medical needs, the status of clinical
trials (so far no toxicity has been observed), and search for development partners.
AACR Special Conference in Cancer Research: Bladder Cancer: Transforming the Field